 | • レポートコード：GIR201115664 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール • 産業分類：機械・機器 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、がん治療における感染管理の世界市場を調査対象にし、がん治療における感染管理の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（放射線療法、免疫療法、トラディショナル手術、幹細胞移植療法、化学療法、標的療法、光力学的療法、その他）、用途別分析（病院、製薬会社、医療機器会社、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Kimberly Clark Corporation、Nordion、Getinge Group AB、3M Healthcare Company、Arizant Healthcare Inc.、Honeywell International, Inc.、Steris Corporation、Sakura Global Holding Company、Sterigenics International、Cisa S.P.A.、Advanced Sterilization Products Services, Inc、Nordion, Inc.、Synergy Health, Plc、Ahlstrom Filtration LLC、Membrana GmbH ・企業別売上、市場シェア ・がん治療における感染管理の地域別市場分析 ・がん治療における感染管理の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・がん治療における感染管理のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・がん治療における感染管理のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・がん治療における感染管理の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・がん治療における感染管理の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・がん治療における感染管理の種類別市場規模2015-2020：放射線療法、免疫療法、トラディショナル手術、幹細胞移植療法、化学療法、標的療法、光力学的療法、その他 ・がん治療における感染管理の用途別市場規模2015-2020：病院、製薬会社、医療機器会社、その他 ・がん治療における感染管理の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Infection Control in Cancer Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Infection Control in Cancer Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Infection Control in Cancer Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Infection Control in Cancer Therapy market has been segmented into:
Radiation Therapy
Immunotherapy
Traditional Surgery
Stem Cell Transplant Therapy
Chemotherapy
Targeted Therapy
Photodynamic Therapy
Other
By Application, Infection Control in Cancer Therapy has been segmented into:
Hospital
Pharmaceutical Companies
Medical device companies
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infection Control in Cancer Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Infection Control in Cancer Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infection Control in Cancer Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Infection Control in Cancer Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Infection Control in Cancer Therapy Market Share Analysis
Infection Control in Cancer Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infection Control in Cancer Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infection Control in Cancer Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Infection Control in Cancer Therapy are:
Kimberly Clark Corporation
Nordion
Getinge Group AB
3M Healthcare Company
Arizant Healthcare Inc.
Honeywell International, Inc.
Steris Corporation
Sakura Global Holding Company
Sterigenics International
Cisa S.P.A.
Advanced Sterilization Products Services, Inc
Nordion, Inc.
Synergy Health, Plc
Ahlstrom Filtration LLC
Membrana GmbH
1 Infection Control in Cancer Therapy Market Overview
1.1 Product Overview and Scope of Infection Control in Cancer Therapy
1.2 Classification of Infection Control in Cancer Therapy by Type
1.2.1 Global Infection Control in Cancer Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Infection Control in Cancer Therapy Revenue Market Share by Type in 2019
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Traditional Surgery
1.2.6 Stem Cell Transplant Therapy
1.2.7 Chemotherapy
1.2.8 Targeted Therapy
1.2.9 Photodynamic Therapy
1.2.10 Other
1.3 Global Infection Control in Cancer Therapy Market by Application
1.3.1 Overview: Global Infection Control in Cancer Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Medical device companies
1.3.5 Other
1.4 Global Infection Control in Cancer Therapy Market by Regions
1.4.1 Global Infection Control in Cancer Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Infection Control in Cancer Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infection Control in Cancer Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Kimberly Clark Corporation
2.1.1 Kimberly Clark Corporation Details
2.1.2 Kimberly Clark Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Kimberly Clark Corporation SWOT Analysis
2.1.4 Kimberly Clark Corporation Product and Services
2.1.5 Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nordion
2.2.1 Nordion Details
2.2.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nordion SWOT Analysis
2.2.4 Nordion Product and Services
2.2.5 Nordion Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Getinge Group AB
2.3.1 Getinge Group AB Details
2.3.2 Getinge Group AB Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Getinge Group AB SWOT Analysis
2.3.4 Getinge Group AB Product and Services
2.3.5 Getinge Group AB Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 3M Healthcare Company
2.4.1 3M Healthcare Company Details
2.4.2 3M Healthcare Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 3M Healthcare Company SWOT Analysis
2.4.4 3M Healthcare Company Product and Services
2.4.5 3M Healthcare Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Arizant Healthcare Inc.
2.5.1 Arizant Healthcare Inc. Details
2.5.2 Arizant Healthcare Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Arizant Healthcare Inc. SWOT Analysis
2.5.4 Arizant Healthcare Inc. Product and Services
2.5.5 Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Honeywell International, Inc.
2.6.1 Honeywell International, Inc. Details
2.6.2 Honeywell International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Honeywell International, Inc. SWOT Analysis
2.6.4 Honeywell International, Inc. Product and Services
2.6.5 Honeywell International, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Steris Corporation
2.7.1 Steris Corporation Details
2.7.2 Steris Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Steris Corporation SWOT Analysis
2.7.4 Steris Corporation Product and Services
2.7.5 Steris Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sakura Global Holding Company
2.8.1 Sakura Global Holding Company Details
2.8.2 Sakura Global Holding Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sakura Global Holding Company SWOT Analysis
2.8.4 Sakura Global Holding Company Product and Services
2.8.5 Sakura Global Holding Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sterigenics International
2.9.1 Sterigenics International Details
2.9.2 Sterigenics International Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sterigenics International SWOT Analysis
2.9.4 Sterigenics International Product and Services
2.9.5 Sterigenics International Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cisa S.P.A.
2.10.1 Cisa S.P.A. Details
2.10.2 Cisa S.P.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cisa S.P.A. SWOT Analysis
2.10.4 Cisa S.P.A. Product and Services
2.10.5 Cisa S.P.A. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Advanced Sterilization Products Services, Inc
2.11.1 Advanced Sterilization Products Services, Inc Details
2.11.2 Advanced Sterilization Products Services, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Advanced Sterilization Products Services, Inc SWOT Analysis
2.11.4 Advanced Sterilization Products Services, Inc Product and Services
2.11.5 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Nordion, Inc.
2.12.1 Nordion, Inc. Details
2.12.2 Nordion, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Nordion, Inc. SWOT Analysis
2.12.4 Nordion, Inc. Product and Services
2.12.5 Nordion, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Synergy Health, Plc
2.13.1 Synergy Health, Plc Details
2.13.2 Synergy Health, Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Synergy Health, Plc SWOT Analysis
2.13.4 Synergy Health, Plc Product and Services
2.13.5 Synergy Health, Plc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Ahlstrom Filtration LLC
2.14.1 Ahlstrom Filtration LLC Details
2.14.2 Ahlstrom Filtration LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Ahlstrom Filtration LLC SWOT Analysis
2.14.4 Ahlstrom Filtration LLC Product and Services
2.14.5 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Membrana GmbH
2.15.1 Membrana GmbH Details
2.15.2 Membrana GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Membrana GmbH SWOT Analysis
2.15.4 Membrana GmbH Product and Services
2.15.5 Membrana GmbH Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Infection Control in Cancer Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Infection Control in Cancer Therapy Players Market Share
3.2.2 Top 10 Infection Control in Cancer Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Regions
4.2 North America Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
5 North America Infection Control in Cancer Therapy Revenue by Countries
5.1 North America Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
5.2 USA Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6 Europe Infection Control in Cancer Therapy Revenue by Countries
6.1 Europe Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
6.2 Germany Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.4 France Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Infection Control in Cancer Therapy Revenue by Countries
7.1 Asia-Pacific Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
7.2 China Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.5 India Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
8 South America Infection Control in Cancer Therapy Revenue by Countries
8.1 South America Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
8.2 Brazil Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Infection Control in Cancer Therapy by Countries
9.1 Middle East & Africa Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Infection Control in Cancer Therapy Market Forecast by Type (2019-2024)
10.3 Radiation Therapy Revenue Growth Rate (2015-2025)
10.4 Immunotherapy Revenue Growth Rate (2015-2025)
10.5 Traditional Surgery Revenue Growth Rate (2015-2025)
10.6 Stem Cell Transplant Therapy Revenue Growth Rate (2015-2025)
10.7 Chemotherapy Revenue Growth Rate (2015-2025)
10.8 Targeted Therapy Revenue Growth Rate (2015-2025)
10.9 Photodynamic Therapy Revenue Growth Rate (2015-2025)
10.10 Other Revenue Growth Rate (2015-2025)
11 Global Infection Control in Cancer Therapy Market Segment by Application
11.1 Global Infection Control in Cancer Therapy Revenue Market Share by Application (2015-2020)
11.2 Infection Control in Cancer Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Pharmaceutical Companies Revenue Growth (2015-2020)
11.5 Medical device companies Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Infection Control in Cancer Therapy Market Size Forecast (2021-2025)
12.1 Global Infection Control in Cancer Therapy Market Size Forecast (2021-2025)
12.2 Global Infection Control in Cancer Therapy Market Forecast by Regions (2021-2025)
12.3 North America Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.6 South America Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Infection Control in Cancer Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Infection Control in Cancer Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Infection Control in Cancer Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Infection Control in Cancer Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Kimberly Clark Corporation Corporate Information, Location and Competitors
Table 6. Kimberly Clark Corporation Infection Control in Cancer Therapy Major Business
Table 7. Kimberly Clark Corporation Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 8. Kimberly Clark Corporation SWOT Analysis
Table 9. Kimberly Clark Corporation Infection Control in Cancer Therapy Product and Solutions
Table 10. Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Nordion Corporate Information, Location and Competitors
Table 12. Nordion Infection Control in Cancer Therapy Major Business
Table 13. Nordion Infection Control in Cancer Therapy Total Revenue (USD Million) (2018-2019)
Table 14. Nordion SWOT Analysis
Table 15. Nordion Infection Control in Cancer Therapy Product and Solutions
Table 16. Nordion Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Getinge Group AB Corporate Information, Location and Competitors
Table 18. Getinge Group AB Infection Control in Cancer Therapy Major Business
Table 19. Getinge Group AB Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 20. Getinge Group AB SWOT Analysis
Table 21. Getinge Group AB Infection Control in Cancer Therapy Product and Solutions
Table 22. Getinge Group AB Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. 3M Healthcare Company Corporate Information, Location and Competitors
Table 24. 3M Healthcare Company Infection Control in Cancer Therapy Major Business
Table 25. 3M Healthcare Company Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 26. 3M Healthcare Company SWOT Analysis
Table 27. 3M Healthcare Company Infection Control in Cancer Therapy Product and Solutions
Table 28. 3M Healthcare Company Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Arizant Healthcare Inc. Corporate Information, Location and Competitors
Table 30. Arizant Healthcare Inc. Infection Control in Cancer Therapy Major Business
Table 31. Arizant Healthcare Inc. Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 32. Arizant Healthcare Inc. SWOT Analysis
Table 33. Arizant Healthcare Inc. Infection Control in Cancer Therapy Product and Solutions
Table 34. Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Honeywell International, Inc. Corporate Information, Location and Competitors
Table 36. Honeywell International, Inc. Infection Control in Cancer Therapy Major Business
Table 37. Honeywell International, Inc. Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 38. Honeywell International, Inc. SWOT Analysis
Table 39. Honeywell International, Inc. Infection Control in Cancer Therapy Product and Solutions
Table 40. Honeywell International, Inc. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Steris Corporation Corporate Information, Location and Competitors
Table 42. Steris Corporation Infection Control in Cancer Therapy Major Business
Table 43. Steris Corporation Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 44. Steris Corporation SWOT Analysis
Table 45. Steris Corporation Infection Control in Cancer Therapy Product and Solutions
Table 46. Steris Corporation Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sakura Global Holding Company Corporate Information, Location and Competitors
Table 48. Sakura Global Holding Company Infection Control in Cancer Therapy Major Business
Table 49. Sakura Global Holding Company Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 50. Sakura Global Holding Company SWOT Analysis
Table 51. Sakura Global Holding Company Infection Control in Cancer Therapy Product and Solutions
Table 52. Sakura Global Holding Company Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Sterigenics International Corporate Information, Location and Competitors
Table 54. Sterigenics International Infection Control in Cancer Therapy Major Business
Table 55. Sterigenics International Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 56. Sterigenics International SWOT Analysis
Table 57. Sterigenics International Infection Control in Cancer Therapy Product and Solutions
Table 58. Sterigenics International Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Cisa S.P.A. Corporate Information, Location and Competitors
Table 60. Cisa S.P.A. Infection Control in Cancer Therapy Major Business
Table 61. Cisa S.P.A. Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 62. Cisa S.P.A. SWOT Analysis
Table 63. Cisa S.P.A. Infection Control in Cancer Therapy Product and Solutions
Table 64. Cisa S.P.A. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Advanced Sterilization Products Services, Inc Corporate Information, Location and Competitors
Table 66. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Major Business
Table 67. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 68. Advanced Sterilization Products Services, Inc SWOT Analysis
Table 69. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Product and Solutions
Table 70. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Nordion, Inc. Corporate Information, Location and Competitors
Table 72. Nordion, Inc. Infection Control in Cancer Therapy Major Business
Table 73. Nordion, Inc. Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 74. Nordion, Inc. SWOT Analysis
Table 75. Nordion, Inc. Infection Control in Cancer Therapy Product and Solutions
Table 76. Nordion, Inc. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Synergy Health, Plc Corporate Information, Location and Competitors
Table 78. Synergy Health, Plc Infection Control in Cancer Therapy Major Business
Table 79. Synergy Health, Plc Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 80. Synergy Health, Plc SWOT Analysis
Table 81. Synergy Health, Plc Infection Control in Cancer Therapy Product and Solutions
Table 82. Synergy Health, Plc Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Ahlstrom Filtration LLC Corporate Information, Location and Competitors
Table 84. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Major Business
Table 85. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 86. Ahlstrom Filtration LLC SWOT Analysis
Table 87. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Product and Solutions
Table 88. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Membrana GmbH Corporate Information, Location and Competitors
Table 90. Membrana GmbH Infection Control in Cancer Therapy Major Business
Table 91. Membrana GmbH Infection Control in Cancer Therapy Total Revenue (USD Million) (2017-2018)
Table 92. Membrana GmbH SWOT Analysis
Table 93. Membrana GmbH Infection Control in Cancer Therapy Product and Solutions
Table 94. Membrana GmbH Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Infection Control in Cancer Therapy Revenue (Million USD) by Players (2015-2020)
Table 96. Global Infection Control in Cancer Therapy Revenue Share by Players (2015-2020)
Table 97. Global Infection Control in Cancer Therapy Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Infection Control in Cancer Therapy Revenue Market Share by Regions (2015-2020)
Table 99. North America Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
Table 100. North America Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Table 101. Europe Infection Control in Cancer Therapy Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Infection Control in Cancer Therapy Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Infection Control in Cancer Therapy Revenue by Countries (2015-2020)
Table 104. South America Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Infection Control in Cancer Therapy Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Table 107. Global Infection Control in Cancer Therapy Revenue (Million USD) by Type (2015-2020)
Table 108. Global Infection Control in Cancer Therapy Revenue Share by Type (2015-2020)
Table 109. Global Infection Control in Cancer Therapy Revenue Forecast by Type (2021-2025)
Table 110. Global Infection Control in Cancer Therapy Revenue by Application (2015-2020)
Table 111. Global Infection Control in Cancer Therapy Revenue Share by Application (2015-2020)
Table 112. Global Infection Control in Cancer Therapy Revenue Forecast by Application (2021-2025)
Table 113. Global Infection Control in Cancer Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Infection Control in Cancer Therapy Picture
Figure 2. Global Infection Control in Cancer Therapy Revenue Market Share by Type in 2019
Figure 3. Radiation Therapy Picture
Figure 4. Immunotherapy Picture
Figure 5. Traditional Surgery Picture
Figure 6. Stem Cell Transplant Therapy Picture
Figure 7. Chemotherapy Picture
Figure 8. Targeted Therapy Picture
Figure 9. Photodynamic Therapy Picture
Figure 10. Other Picture
Figure 11. Infection Control in Cancer Therapy Revenue Market Share by Application in 2019
Figure 12. Hospital Picture
Figure 13. Pharmaceutical Companies Picture
Figure 14. Medical device companies Picture
Figure 15. Other Picture
Figure 16. Global Infection Control in Cancer Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Infection Control in Cancer Therapy Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Infection Control in Cancer Therapy Revenue Market Share in 2019
Figure 25. Global Top 10 Players Infection Control in Cancer Therapy Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Infection Control in Cancer Therapy Revenue Market Share by Regions (2015-2020)
Figure 29. Global Infection Control in Cancer Therapy Revenue Market Share by Regions in 2018
Figure 30. North America Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 31. Europe Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 33. South America Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 35. North America Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. North America Infection Control in Cancer Therapy Revenue Market Share by Countries in 2019
Figure 37. USA Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 38. Canada Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Europe Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Infection Control in Cancer Therapy Revenue Market Share by Countries in 2019
Figure 42. Germany Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 43. UK Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 44. France Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Russia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Italy Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Infection Control in Cancer Therapy Revenue Market Share by Countries in 2019
Figure 49. China Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 50. Japan Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Korea Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 52. India Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 54. South America Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 55. South America Infection Control in Cancer Therapy Revenue Market Share by Countries in 2019
Figure 56. Brazil Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Infection Control in Cancer Therapy Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Infection Control in Cancer Therapy Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 61. UAE Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Infection Control in Cancer Therapy Revenue and Growth Rate (2015-2020)
Figure 64. Global Infection Control in Cancer Therapy Revenue Share by Type (2015-2020)
Figure 65. Global Infection Control in Cancer Therapy Revenue Share by Type in 2019
Figure 66. Global Infection Control in Cancer Therapy Market Share Forecast by Type (2021-2025)
Figure 67. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 69. Global Traditional Surgery Revenue Growth Rate (2015-2020)
Figure 70. Global Stem Cell Transplant Therapy Revenue Growth Rate (2015-2020)
Figure 71. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 72. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 73. Global Photodynamic Therapy Revenue Growth Rate (2015-2020)
Figure 74. Global Other Revenue Growth Rate (2015-2020)
Figure 75. Global Infection Control in Cancer Therapy Revenue Share by Application (2015-2020)
Figure 76. Global Infection Control in Cancer Therapy Revenue Share by Application in 2019
Figure 77. Global Infection Control in Cancer Therapy Market Share Forecast by Application (2021-2025)
Figure 78. Global Hospital Revenue Growth Rate (2015-2020)
Figure 79. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 80. Global Medical device companies Revenue Growth Rate (2015-2020)
Figure 81. Global Other Revenue Growth Rate (2015-2020)
Figure 82. Global Infection Control in Cancer Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Infection Control in Cancer Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Infection Control in Cancer Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
Figure 86. Europe Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
Figure 88. South America Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Infection Control in Cancer Therapy Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
UV感染制御装置の世界市場 2020年 Market Overview The UV Infection Control Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…- 筋骨格障害幹細胞療法の世界市場 2020年 Market Overview The global Musculoskeletal Disorder Stem Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mu…
- 幹細胞治療の世界市場 2020年 Market Overview The Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 感染対策用品の世界市場 2020年 Market Overview The global Infection Control Supplies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infection Control …
- 遺伝子治療の世界市場 2020年 Market Overview The Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…